NovaTract Surgical is a venture-backed startup company founded to develop new, innovative medical devices to address the rapidly growing field of Single-Port Laparoscopic Surgery and Natural Orifice Transluminal Endoscopic Surgery (NOTES).

NovaTract's devices are developed based on the research and expertise of Dr. Kurt E. Roberts, Assistant Professor of General Surgery at Yale University School of Medicine. Dr. Roberts has become one of only a dozen surgeons in the U.S. to perform NOTES procedures and has currently performed the most number of pure NOTES procedures in the country.

NovaTract is developing laparoscopic devices based on his patent-pending technology licensed from Yale University, for performing single-port and NOTES procedures. NovaTract is initially focusing on a retraction device for use in the removal of the gallbladder (cholecystectomies) and appendix (appendectomies) — two markets where laparoscopic surgery with 3-4 incisions is currently the gold standard of care. NovaTract's devices are intended to allow general laparoscopic surgeons worldwide to practice Dr. Roberts’ technique using fewer incisions.

NovaTract was incorporated in April 2010 by its founders, Eleanor L. Tandler, the company’s Chief Executive Officer, and Dr. Roberts. The Company expects its first retraction device to be ready for market in the fourth quarter of 2011.

Website: http://www.novatract.com/